Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Niagen Bioscience, Inc. - Common Stock
(NQ:
NAGE
)
2.775
-0.015 (-0.54%)
Delayed Quote
Updated: 9:31 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Niagen Bioscience, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 06, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
↗
August 06, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook
August 06, 2025
From
Niagen Bioscience, Inc.
Via
Business Wire
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
What's Next: Niagen Bioscience's Earnings Preview
↗
May 06, 2025
Via
Benzinga
Examining the Future: Niagen Bioscience's Earnings Outlook
↗
August 05, 2025
Via
Benzinga
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference
August 04, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 23, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York
July 14, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson’s Disease Therapy in Agreement with Haukeland University Hospital in Bergen, Norway
July 08, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience to Participate at the Roth 15th Annual London Conference
June 20, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience to Participate in the BIO 2025 International Convention
June 11, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder
June 09, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
What 4 Analyst Ratings Have To Say About Niagen Bioscience
↗
June 06, 2025
Via
Benzinga
Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference
June 04, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
May 27, 2025
Via
Benzinga
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook
May 07, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board
April 29, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide
May 05, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
April 28, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs
April 07, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms
March 20, 2025
From
Niagen Bioscience, Inc
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
